Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: AIDS. 2012 Mar 13;26(5):599–607. doi: 10.1097/QAD.0b013e32834fa121

Table 1.

Characteristics of 450 HIV-positive, hepatitis C virus-positive women in Women’s Interagency HIV Study on HAART at index visit.

Characteristicsa Died (N = 191) Alive at last follow-up (N = 259) Overall (N = 450)
Age (years) 44 (40–48) 43 (39–47) 43 (40–47)
Race/ethnicity [% (n)]
   Non-Hispanic white 15 (28) 17 (43) 16 (71)
   Non-Hispanic black 63 (121) 62 (160) 62 (281)
   Hispanic 20 (39) 20 (53) 20 (92)
   Other 2 (3) 1 (3) 1 (6)
Pre-HAART HIV peak viral load (copies/ml) 93 000 (23 000–300 000) 47 000 (9900–140 000) 62000 (13 000–210 000)
Pre-HAART nadir CD4 cell counts (cells/µl) 160 (81–272) 241 (138–345) 205 (102–316)
Clinical AIDS pre-HAART initiation [% (n)] 61 (116) 42 (110) 50 (226)
Pre-HAART ART use [% (n)] 79 (151) 66 (170) 71 (321)
HIV viral load (copies/ml) 2250 (81–34 000) 173 (80–3600) 570 (80–13 000)
CD4 cell counts (cells/µl) 230 (128–375) 351 (200–516) 313 (169–469)
HCV-RNA, ×103 IU/ml at entry into WIHS 2880 (926–4960) 1760 (551–3760) 2085 (645–4020)
HBsAg-positive, % (n) at entry into WIHS 3 (5) 2 (4) 2 (9)
Current alcohol use [% (n)]
   Abstinent 60 (115) 59 (152) 59 (267)
   Light (<3 drinks/week) 15 (28) 24 (63) 20 (91)
   Moderate (3–13 drinks/week) 16 (31) 11 (29) 1% (60)
   Heavy (>13 drinks/week) 7 (13) 4 (10) 5 (23)
Current IVDU -[% (n)] 12 (23) 8 (20) 10 (43)
BMI (kg/m2) 25.3 (21.4–28.9) 25.6 (23.4–29.7) 25.4 (22.7–29.3)
Waist circumference (cm) 81 (75–91) 87 (80–97) 86 (78–95)
Diabetes [% (n)] 6 (11) 4 (11) 5 (22)
Chronic renal disease [% (n)] 14 (26) 3 (8) 8 (34)
AST (IU/l) 53 (34–84) 42 (33–60) 46 (33–68)
ALT (IU/l) 35 (23–63) 37 (26–62) 36 (25–62)
Follow-up time (years) 4.3 (1.8–7.4) 8.5 (5.7–10.7) 6.6 (3.2–9.8)

ALT, alanine aminotransferase; ART, antiretroviral therapy; AST, aspartate aminotransferase; HBsAg, surface antigen; HCV, hepatitis C virus; IVDU, intravenous drug use; WIHS, Women’s Interagency HIV Study.

a

Median (interquartile range) unless otherwise noted. Values are for index visit unless otherwise indicated.

The following characteristics had missing data: pre-HAART HIV peak viral load, n = 2; pre-HAART nadir CD4, n = 1; HIV viral load at index visit, 0 = 20; CD4 cell count at index visit, n = 5; BMI, n = 13; waist, n = 291; current alcohol use, n = 9; and current IVDU, n = 8.